Related content

Interleukin-1 as a therapeutic target in systemic-onset juvenile idiopathic arthritis

By Allantaz Florence   Stichweh Dorothee   Pascual Virginia  

Future Rheumatology, Vol. 2, Iss. 3, 2007-06 ,pp. : 305-312

Future Medicine

Access to resources Recommend Favorite

Inflammatory cytokines and systemic-onset juvenile idiopathic arthritis

By Yokota Shumpei   Miyamae Takako   Imagawa Tomoyuki   Iwata Naomi   Katakura Shigeki   Mori Masaaki  

Modern Rheumatology, Vol. 14, Iss. 1, 2004-03 ,pp. : 12-17

Springer Publishing Company

Access to resources Recommend Favorite

Leukocytapheresis for the treatment of refractory systemic-onset juvenile idiopathic arthritis

By Tanaka Hiroshi   Tsugawa Koji   Nakahata Tohru   Suzuki Koichi   Ito Etsuro  

Clinical Rheumatology, Vol. 26, Iss. 6, 2007-06 ,pp. : 1014-1016

Springer Publishing Company

Access to resources Recommend Favorite

Leflunomide in juvenile idiopathic arthritis

By Silverman Earl   Strand Vibeke  

Future Rheumatology, Vol. 1, Iss. 6, 2006-12 ,pp. : 673-682

Future Medicine

Access to resources Recommend Favorite

Outcome in adults with juvenile idiopathic arthritis

By Bruinooge L.N.   Moussaoui R. El   Taal E.   Dijkmans B.A.C.   Van Soesbergen R.M.  

Scandinavian Journal of Rheumatology, Vol. 32, Iss. 2, 2003-01 ,pp. : 89-94

Informa Healthcare

Access to resources Recommend Favorite